ADAM10 Promotes Cell Growth, Migration, and Invasion in Osteosarcoma Via Regulating E-cadherin/β-catenin Signaling Pathway and is Regulated by MiR-122-5p

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2020 Apr 8

PMID 32256208

Citations 9

Authors

Quan Yuan

Honghao Yu

Jianhua Chen

Xiaoyu Song

Li Sun

Affiliations

Soon will be listed here.

Abstract

Background: Osteosarcoma is a malignant bone tumor. Increasing evidences have revealed that a disintegrin and metalloproteinase 10 (ADAM10) is implicated in tumor development. The main purpose of this study is to explore the effects of ADAM10 on osteosarcoma cell functions and the underlying molecular mechanisms.

Methods: Western blot and quantitative real-time PCR were performed to detect the expression of ADAM10 in one osteoblast (hFOB 1.19) and six osteosarcoma cells (Saos-2, SW1353, HOS, U-2OS, MG63, and 143B). The biological functions of ADAM10 in osteosarcoma cells were measured by cell counting kit-8 assay, flow cytometry, wound healing assay, and transwell assay. The interaction between miR-122-5p and ADAM10 was validated using dual-luciferase reporter assay. The effect of ADAM10 on the tumorigenicity of osteosarcoma cells was evaluated in a nude mice model in vivo.

Results: We found that the expression of ADAM10 was relatively high in osteosarcoma cells compared with that in osteoblast. ADAM10 promoted osteosarcoma cell growth, migration, and invasion. Mechanism studies showed that knockdown of ADAM10 inactivated E-cadherin/β-catenin signaling pathway, as evidenced by increased the level of E-cadherin, reduced nuclear translocation of β-catenin, and decreased the levels of MMP-9, Cyclin D1, c-Myc, and Survivin. Downregulation of ADAM10 suppressed the tumorigenicity of osteosarcoma cells in vivo. Furthermore, ADAM10 was validated to be a downstream target of microRNA-122-5p (miR-122-5p). MiR-122-5p-induced inhibition of cell proliferation, migration, and invasion was reversed by overexpression of ADAM10 in osteosarcoma cells.

Conclusions: Collectively, the key findings of this study are that ADAM10 promotes osteosarcoma cell proliferation, migration, and invasion by regulating E-cadherin/β-catenin signaling pathway, and miR-122-5p can target ADAM10, indicating that miR-122-5p/ADAM10 axis might serve as a therapeutic target of osteosarcoma.

Citing Articles

ADAM10 is a key player in the diagnosis, prognosis and metastasis of non-small cell lung cancer (NSCLC).

Zhang W, Yang L, Li M, Zhang L, Cheng J, El-Far A J Cancer. 2025; 16(5):1736-1746.

PMID: 39991567 PMC: 11843235. DOI: 10.7150/jca.107236.

The Yin and Yang of the Natural Product Triptolide and Its Interactions with XPB, an Essential Protein for Gene Expression and DNA Repair.

Gorrie D, Bravo M, Fan L Genes (Basel). 2024; 15(10).

PMID: 39457411 PMC: 11507457. DOI: 10.3390/genes15101287.

Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis.

Huang Y, Cao D, Zhang M, Yang Y, Niu G, Tang L Cell Oncol (Dordr). 2024; 47(5):1715-1733.

PMID: 38652223 PMC: 11467127. DOI: 10.1007/s13402-024-00949-3.

Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis.

Ahn Y, Park J Biomol Ther (Seoul). 2024; 32(3):291-300.

PMID: 38589290 PMC: 11063481. DOI: 10.4062/biomolther.2023.207.

MicroRNAs and proteolytic cleavage of receptors in cancers: A comprehensive review of regulatory interactions and therapeutic implications.

Hosseinpour-Soleimani F, Salmasi Z, Ghasemi Y, Tajbakhsh A, Savardashtaki A Heliyon. 2024; 10(7):e28167.

PMID: 38560206 PMC: 10979173. DOI: 10.1016/j.heliyon.2024.e28167.

References

Yoneyama T, Gorry M, Sobo-Vujanovic A, Lin Y, Vujanovic L, Gaither-Davis A . ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker. J Cancer. 2018; 9(14):2559-2570. PMC: 6036891. DOI: 10.7150/jca.24601. View

Esteve P, Sandonis A, Cardozo M, Malapeira J, Ibanez C, Crespo I . SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis. Nat Neurosci. 2011; 14(5):562-9. DOI: 10.1038/nn.2794. View

Mori H, Tomiyasu T, Nishiyama K, Matsumoto M, Osawa Y, Okazaki K . L233P mutation in the bovine leukemia virus Tax protein depresses endothelial cell recruitment and tumorigenesis in athymic nude mice. Arch Virol. 2019; 164(5):1343-1351. DOI: 10.1007/s00705-019-04191-3. View

Zhao R, Ni D, Tian Y, Ni B, Wang A . Aberrant ADAM10 expression correlates with osteosarcoma progression. Eur J Med Res. 2014; 19:9. PMC: 3936952. DOI: 10.1186/2047-783X-19-9. View

Arima T, Enokida H, Kubo H, Kagara I, Matsuda R, Toki K . Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Sci. 2007; 98(11):1720-6. PMC: 11158887. DOI: 10.1111/j.1349-7006.2007.00601.x. View

Anderegg U, Eichenberg T, Parthaune T, Haiduk C, Saalbach A, Milkova L . ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells. J Invest Dermatol. 2008; 129(6):1471-82. DOI: 10.1038/jid.2008.323. View

Ding C, Zhang Q, Chen Y, Zhang X, Wu P, Zhang Z . Overexpression of A disintegrin and metalloprotease 10 promotes tumor proliferation, migration and poor prognosis in hypopharyngeal squamous cell carcinoma. Oncol Rep. 2017; 38(2):866-874. PMC: 5562066. DOI: 10.3892/or.2017.5761. View

Novellasdemunt L, Antas P, Li V . Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. Am J Physiol Cell Physiol. 2015; 309(8):C511-21. PMC: 4609654. DOI: 10.1152/ajpcell.00117.2015. View

Fu L, Liu N, Han Y, Xie C, Li Q, Wang E . ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells. Tumour Biol. 2014; 35(9):9263-8. DOI: 10.1007/s13277-014-2201-9. View

10.

Ren Z, Liang S, Yang J, Han X, Shan L, Wang B . Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma. Tumour Biol. 2015; 37(4):5089-96. DOI: 10.1007/s13277-015-4352-8. View

11.

Guo J, Du J, Fei D, Xing J, Liu J, Lu H . miR‑152 inhibits rheumatoid arthritis synovial fibroblast proliferation and induces apoptosis by targeting ADAM10. Int J Mol Med. 2018; 42(1):643-650. DOI: 10.3892/ijmm.2018.3636. View

12.

Edwards D, Handsley M, Pennington C . The ADAM metalloproteinases. Mol Aspects Med. 2008; 29(5):258-89. PMC: 7112278. DOI: 10.1016/j.mam.2008.08.001. View

13.

Xu X, Gao F, Wang J, Tao L, Ye J, Ding L . MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4. Cancer Biol Ther. 2018; 19(5):427-435. PMC: 5915035. DOI: 10.1080/15384047.2018.1423925. View

14.

Isakoff M, Bielack S, Meltzer P, Gorlick R . Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol. 2015; 33(27):3029-35. PMC: 4979196. DOI: 10.1200/JCO.2014.59.4895. View

15.

Gangemi R, Amaro A, Gino A, Barisione G, Fabbi M, Pfeffer U . ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion. Pigment Cell Melanoma Res. 2014; 27(6):1138-48. DOI: 10.1111/pcmr.12306. View

16.

Liu Y, Zhang W, Liu S, Liu K, Ji B, Wang Y . miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma. Oncol Rep. 2017; 37(3):1857-1864. DOI: 10.3892/or.2017.5423. View

17.

You B, Shan Y, Shi S, Li X, You Y . Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma. Cancer Sci. 2015; 106(11):1506-14. PMC: 4714676. DOI: 10.1111/cas.12800. View

18.

Meng H, Huang Q, Zhang X, Huang J, Shen R, Zhang B . MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10. Onco Targets Ther. 2019; 12:3829-3838. PMC: 6529029. DOI: 10.2147/OTT.S190282. View

19.

Zhang L, Zhao L, Yan X, Huang Y . Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways. J Cell Physiol. 2019; 234(11):20469-20484. DOI: 10.1002/jcp.28648. View

20.

Moss M, Lambert M . Shedding of membrane proteins by ADAM family proteases. Essays Biochem. 2002; 38:141-53. DOI: 10.1042/bse0380141. View